{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:32:30Z","timestamp":1786120350499,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1097\/jcp.0b013e31823f6b6a","type":"journal-article","created":{"date-parts":[[2011,12,24]],"date-time":"2011-12-24T11:48:34Z","timestamp":1324727314000},"page":"100-105","source":"Crossref","is-referenced-by-count":10,"title":["Does the Medication Pattern Reflect the CYP2D6 Genotype in Patients With Diagnoses Within the Schizophrenic Spectrum?"],"prefix":"10.1097","volume":"32","author":[{"given":"Gesche","family":"J\u00fcrgens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik B.","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Werge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Dalhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merete","family":"Nordentoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stig E.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210128","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.clpt.2005.08.013","article-title":". Drug-metabolizing enzymes: evidence for clinical utility of pharmacogenomic tests.","volume":"78","author":"Andersson","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"R2-16-20210128","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2165\/00023210-200923030-00001","article-title":"Cytochrome P450 2D6 genotyping: potential role in improving treatment outcomes in psychiatric disorders.","volume":"23","author":"Kirchheiner","year":"2009","journal-title":"CNS Drugs"},{"key":"R4-16-20210128","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.0306-5251.2001.01548.x","article-title":". Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs.","volume":"53","author":"Bertilsson","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"R5-16-20210128","first-page":"136","article-title":"Pharmacogenetics in psychiatrya useful clinical tool or wishful thinking for the future Curr Pharm Des.","volume":"16","author":"Kirchheiner","year":"2010","journal-title":""},{"key":"R6-16-20210128","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.4088\/JCP.v68n1115","article-title":". The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update.","volume":"68","author":"Moore","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R9-16-20210128","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/sj.mp.4001494","article-title":". Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response.","volume":"9","author":"Kirchheiner","year":"2004","journal-title":"Mol Psychiatry"},{"key":"R10-16-20210128","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0022-3956(74)90071-5","article-title":"Dose equivalence of the antipsychotic drugs.","volume":"11","author":"Davis","year":"1974","journal-title":"J Psychiatr Res"},{"key":"R11-16-20210128","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4088\/JCP.v64n0607","article-title":"Chlorpromazine equivalent doses for the newer atypical antipsychotics.","volume":"64","author":"Woods","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R12-16-20210128","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.biopsych.2009.08.040","article-title":". Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs.","volume":"67","author":"Andreasen","year":"2010","journal-title":"Biol Psychiatry"},{"key":"R15-16-20210128","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/clinchem\/46.8.1072","article-title":". Rapid detection of the CYP2D63, CYP2D64, and CYP2D66 alleles by tetra-primer PCR and of the CYP2D65 allele by multiplex long PCR.","volume":"46","author":"Hersberger","year":"2000","journal-title":"Clin Chem"},{"key":"R16-16-20210128","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0014-5793(96)00779-X","article-title":". Ultrarapid metabolizers of debrisoquine: characterization and PCR-based detection of alleles with duplication of the CYP2D6 gene.","volume":"392","author":"Lovlie","year":"1996","journal-title":"FEBS Lett"},{"key":"R17-16-20210128","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1517\/14622416.3.2.229","article-title":"CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants.","volume":"3","author":"Bradford","year":"2002","journal-title":"Pharmacogenomics"},{"key":"R18-16-20210128","doi-asserted-by":"crossref","first-page":"e873","DOI":"10.1371\/journal.pone.0000873","article-title":". Brain expressed microRNAs implicated in schizophrenia etiology.","volume":"2","author":"Hansen","year":"2007","journal-title":"PLoS One"},{"key":"R19-16-20210128","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.biopsych.2011.01.031","article-title":". At-risk variant in TCF7L2 for type II diabetes increases risk of schizophrenia.","volume":"70","author":"Hansen","year":"2011","journal-title":"Biol Psychiatry"},{"key":"R20-16-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","article-title":". The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients.","volume":"334","author":"Lingjaerde","year":"1987","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"R21-16-20210128","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3371\/CSRP.5.1.6","article-title":"Schizophrenia treatment guidelines in the United States.","volume":"5","author":"Moore","year":"2011","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"R22-16-20210128","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1176\/appi.ajp.161.3.414","article-title":"Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.","volume":"161","author":"Correll","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R23-16-20210128","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/JCP.0b013e3181fab7ca","article-title":". A comparison of antipsychotic drug-defined daily doses versus chlorpromazine equivalent doses in patients with or without extrapyramidal motor symptoms.","volume":"30","author":"Barr","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"R24-16-20210128","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.tpj.6500285","article-title":"Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity.","volume":"5","author":"Ingelman-Sundberg","year":"2005","journal-title":"Pharmacogenomics J"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004714-201202000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:30:33Z","timestamp":1786048233000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-201202000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e31823f6b6a","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}